| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | AFFIMED N V COM | 62,500 | 394,000 | 0.30% | SH | |
| 52 | EPIZYME INC COM | 20,000 | 376,000 | 0.29% | ||
| 53 | LUMENIS LTD | 31,072 | 372,000 | 0.29% | SH | |
| 54 | Aldeyra Therapeutics Inc | 35,000 | 356,000 | 0.27% | ||
| 55 | GALENA BIOPHARMA INC | 250,000 | 348,000 | 0.27% | ||
| 56 | VENAXIS INC | 658,000 | 305,000 | 0.23% | SH | |
| 57 | CUTERA INC COM | 23,490 | 303,000 | 0.23% | SH | |
| 58 | GENVEC INC | 100,000 | 295,000 | 0.23% | SH | |
| 59 | LPATH INC | 111,884 | 276,000 | 0.21% | SH | |
| 60 | BOVIE MEDICAL CORP COM | 100,000 | 239,000 | 0.18% | ||
| 61 | ACTINIUM PHARMACEUTICALS INC | 90,000 | 222,000 | 0.17% | ||
| 62 | TRANSITION THERAPEUTICS INC | 26,410 | 180,000 | 0.14% | ||
| 63 | NANOSPHERE INC | 600,000 | 139,000 | 0.11% | SH | |
| 64 | CAS MED SYS INC | 100,000 | 134,000 | 0.10% | ||
| 65 | APTOSE BIOSCIENCES INC | 22,289 | 121,000 | 0.09% | ||
| 66 | CHEMBIO DIAGNOSTICS INC COM NEW | 26,287 | 106,000 | 0.08% | SH | |
| 67 | FATE THERAPEUTICS INC | 20,190 | 99,000 | 0.08% | SH | |
| 68 | TONIX PHARMACEUTICALS HOLDING | 14,400 | 91,000 | 0.07% | SH | |
| 69 | GLOBEIMMUNE INC | 9,445 | 69,000 | 0.05% | SH | |
| 70 | CHECK CAP LTD | 55,000 | 55,000 | 0.04% | ||
| 71 | OPEXA THERAPEUTICS EQUITY WARRANTS 03/13/201 | 500 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-15-000013, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
